Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Amicus Therapeutics Inc

FOLD
Current price
10.13 USD +0.26 USD (+2.63%)
Last closed 9.73 USD
ISIN US03152W1099
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 976 108 032 USD
Yield for 12 month -11.53 %
1Y
3Y
5Y
10Y
15Y
FOLD
21.11.2021 - 28.11.2021

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset. It has collaboration and license agreements with the University of Pennsylvania to research and develop parvovirus gene therapy products; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey. Address: 47 Hulfish Street, Princeton, NJ, United States, 08542

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

17.75 USD

P/E ratio

Dividend Yield

Current Year

+399 356 000 USD

Last Year

+329 233 000 USD

Current Quarter

+141 517 000 USD

Last Quarter

+126 669 000 USD

Current Year

+362 030 000 USD

Last Year

+290 634 000 USD

Current Quarter

+128 238 000 USD

Last Quarter

+113 226 000 USD

Key Figures FOLD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 23 089 000 USD
Operating Margin TTM 17.53 %
PE Ratio
Return On Assets TTM 1.16 %
PEG Ratio -0.18
Return On Equity TTM -67.09 %
Wall Street Target Price 17.75 USD
Revenue TTM 493 671 008 USD
Book Value 0.6 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 36.7 %
Dividend Yield
Gross Profit TTM 290 634 000 USD
Earnings per share -0.34 USD
Diluted Eps TTM -0.34 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -21.21 %

Dividend Analytics FOLD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History FOLD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation FOLD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 33.4448
Enterprise Value Revenue 6.4354
Price Sales TTM 6.0285
Enterprise Value EBITDA -35.9859
Price Book MRQ 16.676

Financials FOLD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators FOLD

For 52 weeks

9.02 USD 14.57 USD
50 Day MA 10.73 USD
Shares Short Prior Month 19 897 821
200 Day MA 10.9 USD
Short Ratio 7.28
Shares Short 20 997 095
Short Percent 7.07 %